SSII - SS Innovations International, Inc.
NEXT EARNINGS:
Feb 10, 2026
(in 0 days)
Price:
--
--
Market Cap:
877.10M
Volume:
268,731
Avg Volume:
87,326
52 Week Range:
3.015-22.42
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.52
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
378
IPO Date:
2018-10-17
EPS (TTM):
-0.11
P/E Ratio:
-70.36
Revenue (TTM):
20.65M
Total Assets:
42.39M
Total Debt:
18.20M
Cash & Equiv:
466,500
Rev Growth (5Y):
276.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-86.3%
Debt/Equity:
1.35
Track Record
Statements >| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.65M | 5.88M | 1.46M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | (19.15M) | (20.94M) | (5.60M) | (1.48M) | (1.12M) | (3.39M) | (960,322) | (1.04M) | (484,982) | (66) |
| EPS | -0.11 | -0.16 | -1.41 | -0.52 | -0.48 | -1.57 | -0.46 | -0.53 | -0.25 | N/A |
| Total Assets | 42.39M | 25.48M | 6.98M | 428,607 | 317,870 | 132,524 | 145,434 | 509,962 | 292,232 | N/A |
| Total Debt | 18.20M | 8.22M | 8.27M | 145,000 | 195,000 | 457,500 | 15,000 | N/A | 480,000 | N/A |
| Cash & Equivalents | 466,500 | 7.03M | 217,177 | 405,774 | 160,709 | 28,474 | 35,716 | 452,572 | 248,219 | N/A |
| Operating Cash Flow | (9.50M) | (15.36M) | (5.99M) | (363,034) | (90,540) | (424,105) | (443,288) | (446,856) | (190,233) | N/A |
| Free Cash Flow | (10.16M) | (15.81M) | (1.44M) | (363,034) | (94,540) | (474,227) | (466,856) | (451,030) | (233,781) | N/A |
| FCF per Share | -0.06 | -0.12 | -0.36 | -0.13 | -0.04 | -0.22 | -0.22 | -0.23 | -0.12 | N/A |
| Book Value | 13.46M | 14.30M | (2.68M) | 141,326 | (869,049) | (1.06M) | (304,349) | 101,093 | (355,060) | N/A |
| Cash & ST Investments | 466,500 | 7.03M | 217,177 | 405,774 | 160,709 | 28,474 | 35,716 | 452,572 | 248,219 | N/A |
| ROC Equity | -1.42 | -1.46 | N/A | -10.50 | N/A | N/A | N/A | -10.27 | N/A | N/A |